InSysBio to present at the ASCPT 2018 Annual Meeting

September 2020

9 1. 09 Sep 2020 14:59 InSysBio to update its Cytocon DB to version 1.2.6.7 InSysBio announces the new version of Cytocon DB 1.2.6.7! Cytocon DB team has reviewed 39 articles to implement the new data. It should be highlighted that the total number of reviewed articles within the Database has already exceeded 515!

16 1. 16 Sep 2020 14:54 InSysBio to take part in ACoP11 InSysBio announces its participation in Eleventh American Conference on Pharmacometrics (ACoP11) which is to be held in virtual format this year due to COVID-19 spread 9-13 November, 2020. The theme of ACoP11 is “Scaling New Heights.” InSysBio team is going to present 9 posters in frames of the Conference

23 1. 23 Sep 2020 10:26 InSysBio announces its collaboration with Genmab The new partnership strives to evaluate the efficacy of a new oncology therapy – GEN1042 (DuoBody®-CD40x4-1BB) [Moscow, Russia; Princeton, New Jersey, U.S. – 23.09.2020] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

events

Conference

March 15, 2018

March 12, 2018

InSysBio today announced their participation at AAT-AD/PD Focus Meeting 2018, to be held in Torino, Italy, on March 15-18, 2018. The Meeting is focused on all the latest breakthroughs in treatment and research in Alzheimer’s, Parkinson’s and other neurological diseases. Alexander Stepanov will present “In silico implementation of tauopathy transgenic mouse model” in the framework of session “Symposium 25: Tau in translational studies (2)”.a

March 15, 2018

InSysBio today announced their participation at the ASCPT 2018 Annual Meeting, to be held in Orlando, FL, on March 21-24. Five InSysBio posters will be presented in two poster sessions.

Encore Poster Session (21 March, 5:00 PM – 6:30 PM):

“PBPK modeling for therapeutic nanoparticles loaded with drug: distribution and release”
by Oleg Demin(poster number E-005)

“Translational QSP model of amyloid beta allows to predict both short and long term response of AD patients to different therapies”
by Tatiana Karelina (poster number E-006)

Poster Session II (23 March, 7:00 AM – 8:30 AM):

“Multiple myeloma quantitative systems pharmacology model: development and usage for pomalidomide influence evaluation”
by Svetlana Rubina (poster number PII-115)

“Quantitative Systems pharmacology model of bispecific antibodies and CAR-T in acute lymphoblastic leukemia”
by Oleg Demin Jr (poster number PII-035)

“Different tau pathology variants can be described by unique QSP model structure for therapy outcome prediction”
by Tatiana Karelina (poster number PII-065)

←	September 2020	→
Mo	Tu	We	Th	Fr	Sa	Su
	1	2	3	4	5	6
7	8	9 1. 09 Sep 2020 14:59 InSysBio to update its Cytocon DB to version 1.2.6.7 InSysBio announces the new version of Cytocon DB 1.2.6.7! Cytocon DB team has reviewed 39 articles to implement the new data. It should be highlighted that the total number of reviewed articles within the Database has already exceeded 515!	10	11	12	13
14	15	16 1. 16 Sep 2020 14:54 InSysBio to take part in ACoP11 InSysBio announces its participation in Eleventh American Conference on Pharmacometrics (ACoP11) which is to be held in virtual format this year due to COVID-19 spread 9-13 November, 2020. The theme of ACoP11 is “Scaling New Heights.” InSysBio team is going to present 9 posters in frames of the Conference	17	18	19	20
21	22	23 1. 23 Sep 2020 10:26 InSysBio announces its collaboration with Genmab The new partnership strives to evaluate the efficacy of a new oncology therapy – GEN1042 (DuoBody®-CD40x4-1BB) [Moscow, Russia; Princeton, New Jersey, U.S. – 23.09.2020] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.	24	25	26	27
28	29	30

Upcoming Events